Determination of high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in the same population of cultured cells

Brain Research

Volumn 1297, Issue , 2009, Pages 160-168

  Ray, Balmiki ^a   Simon, Jay R ^a   Lahiri, Debomoy K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; ChAT; Choline uptake; Differentiation; Enzyme assay; HACU; Neurodegenerative disorders; Neuronal cells; Tissue culture

Indexed keywords

CHOLINE; CHOLINE ACETYLTRANSFERASE;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL KINETICS; CELL POPULATION; CHOLINE UPTAKE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEUROCHEMISTRY; PRIORITY JOURNAL;

ACETYLCHOLINE; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC AGENTS; CHOLINERGIC FIBERS; DRUG EVALUATION, PRECLINICAL; ENZYME ASSAYS; HEMICHOLINIUM 3; HUMANS; MEMBRANE TRANSPORT PROTEINS; NEUROCHEMISTRY; NEURONS; RADIOISOTOPES;

MAMMALIA;

EID: 71749111450     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.07.096     Document Type: Article

References (12)

1. Apparsundaram S., Ferguson S.M., George Jr. A.L., and Blakely R.D. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem. Biophys. Res. Commun. 276 (2000) 862-867
2. Bennett K.M., Hoelting C., Martin C.P., and Stoll J. Estrogen effects on high-affinity choline uptake in primary cultures of rat basal forebrain. Neurochem. Res. 34 (2009) 205-214
3. Birks, J., Grimley Evans, J., Iakovidou, V., Tsolaki, M., Holt, F.E., 2009. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. CD001191.
4. Crouch S.P., Kozlowski R., Slater K.J., and Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods 160 (1993) 81-88
5. Fonnum F. Recent developments in biochemical investigations of cholinergic transmission. Brain Res. 62 (1973) 497-507
6. Ginsberg S.D., Che S., Wuu J., Counts S.E., and Mufson E.J. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J. Neurochem. 97 (2006) 475-487
7. Lahiri D.K., Nall C., and Ge Y.W. Promoter activity of the beta-amyloid precursor protein gene is negatively modulated by an upstream regulatory element. Brain Res. Mol. Brain Res. 71 (1999) 32-41
8. Lahiri D.K., Farlow M.R., Sambamurti K., Greig N.H., Giacobini E., and Schneider L.S. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets 4 (2003) 97-112
9. Pizzi M., Boroni F., Bianchetti A., Moraitis C., Sarnico I., Benarese M., Goffi F., Valerio A., and Spano P. Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur. J. Neurosci. 16 (2002) 2342-2350
10. Simon J.R., and Kuhar M.G. Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminals. Nature 255 (1975) 162-163
11. Simon J.R., Atweh S., and Kuhar M.J. Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J. Neurochem. 26 (1976) 909-922
12. Wainwright L.J., Lasorella A., and Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9396-9400